1-3 of 3
Alison M Paterson, PhD
Close
Sort by
Journal Articles

The Fully Human Anti-CD47 Antibody SRF231 Has Dual-Mechanism Antitumor Activity Against Chronic Lymphocytic Leukemia (CLL) Cells and Increases the Activity of Both Rituximab and Venetoclax

Rebecca Valentin, MD, Marisa O. Peluso, MS, Timothy Z. Lehmberg, BA, Ammar Adam, DVM, Li Zhang, MA, Caroline M. Armet, BS, Jennifer L. Guerriero, PhD, Benjamin H. Lee, MD PhD, Vito J. Palombella, PhD, Pamela M. Holland, PhD, Alison M. Paterson, PhD, Matthew S. Davids, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4393.
https://doi.org/10.1182/blood-2018-99-110181
Published: 2018
Journal Articles

Targeted Inhibition of CD47-Sirp Alpha Requires Fc-Fc Gamma Receptor Interactions to Maximize Phagocytosis in T-Cell Lymphomas

Salvia Jain, MD, Alexandria Van Scoyk, Elizabeth A Morgan, MD, Andrew Matthews, MD, Kristen E. Stevenson, MS, Gail Newton, PhD, Anu K Autio, PhD, Marisa O. Peluso, MS, Rachel W O'Connor, BS, Alison M. Paterson, PhD, Pamela M. Holland, PhD, Francis W Luscinskas, PhD, David M Weinstock, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 339.
https://doi.org/10.1182/blood-2018-99-112986
Published: 2018
Journal Articles

CD47 Monoclonal Antibody SRF231 Is a Potent Inducer of Macrophage-Mediated Tumor Cell Phagocytosis and Reduces Tumor Burden in Murine Models of Hematologic Malignancies

Pamela M Holland, PhD, Emmanuel Normant, PhD, Ammar Adam, DVM, Caroline M Armet, BS, Rachel W O'Connor, BS, Andrew C Lake, PhD, Jonathan A Hill, PhD, Detlev M Biniskiewicz, PhD, Scott C Chappel, PhD, Vito J Palombella, PhD, Alison M Paterson, PhD
Journal: Blood
Blood (2016) 128 (22): 1843.
https://doi.org/10.1182/blood.V128.22.1843.1843
Published: 2016